CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"FDA halts release of new drug rejection letters while working to formalize policy","$":{"href":"/biotech/fda-halts-release-new-drug-rejection-letters-while-working-formalize-policy","hreflang":"en"}}]}

RegulatoryNegative
AI Analysis

Summary

The FDA has paused its policy of releasing drug rejection letters following a citizen petition from an unnamed pharma company in April. The agency is working to formalize its approach to releasing such communications.

Outcome Details

FDA paused release of drug rejection letters following citizen petition

Importance:4/10
Sentiment:
-0.30
FDAregulatory policydrug rejectiontransparencycitizen petition
Related Companies

Read the original article

Published by FierceBiotech on July 8, 2026 1:06 PM

Read Original